Jamie Dananberg Unity Biotechnology, Inc. (UBX) insider trading activity

Jamie Dananberg is Chief Medical Officer of Unity Biotechnology, Inc.. Currently has a direct ownership of 62,817 shares of UBX, which is worth approximately $82,290. The most recent transaction as insider was on Mar 31, 2023, when has been sold 420 shares (Common Stock, $0.0001 par value) at a price of $1.7 per share, resulting in proceeds of $714. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.8K

0% 3M change

0% 12M change

Total Value Held $82,290

Jamie Dananberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2023	SELL Open market or private sale	$714 $1.7 p/Share	420 Reduced 0.66%	62,817 Common Stock, $0.0001 ...
Mar 14 2023	SELL Open market or private sale	$4,020 $4.0 p/Share	1,005 Reduced 1.56%	63,237 Common Stock, $0.0001 ...
Feb 02 2023	SELL Open market or private sale	$4,176 $4.84 p/Share	863 Reduced 1.33%	64,242 Common Stock, $0.0001 ...
Dec 14 2022	SELL Open market or private sale	$2,895 $2.85 p/Share	1,016 Reduced 1.54%	65,105 Common Stock, $0.0001 ...
Sep 14 2022	SELL Open market or private sale	$5,243 $0.48 p/Share	10,923 Reduced 1.63%	661,213 Common Stock, $0.0001 ...
Jun 27 2022	SELL Open market or private sale	$2,595 $0.59 p/Share	4,398 Reduced 0.65%	672,136 Common Stock, $0.0001 ...
Jun 21 2022	SELL Open market or private sale	$2,292 $0.62 p/Share	3,697 Reduced 0.54%	676,534 Common Stock, $0.0001 ...

Jun 14 2022	SELL Payment of exercise price or tax liability	$6,634 $0.63 p/Share	10,530 Reduced 1.52%	680,231 Common Stock, $0.0001 ...
Mar 31 2022	SELL Payment of exercise price or tax liability	$4,774 $1.14 p/Share	4,188 Reduced 0.6%	690,761 Common Stock, $0.0001 ...
Mar 14 2022	SELL Payment of exercise price or tax liability	$9,311 $0.88 p/Share	10,581 Reduced 1.5%	694,949 Common Stock, $0.0001 ...
Feb 09 2022	BUY Grant, award, or other acquisition	-	45,833 Added 6.1%	705,530 Common Stock, $0.0001 ...
Dec 14 2021	SELL Payment of exercise price or tax liability	$17,301 $1.63 p/Share	10,614 Reduced 1.58%	659,697 Common Stock, $0.0001 ...
Jun 24 2021	BUY Grant, award, or other acquisition	-	25,000 Added 3.4%	710,875 Common Stock, $0.0001 ...
Jun 21 2021	SELL Payment of exercise price or tax liability	$14,693 $4.18 p/Share	3,515 Reduced 0.51%	685,875 Common Stock, $0.0001 ...
Mar 30 2021	SELL Payment of exercise price or tax liability	$119,664 $2.95 p/Share	40,564 Reduced 5.71%	670,311 Common Stock, $0.0001 ...
Mar 30 2021	SELL Payment of exercise price or tax liability	$16,210 $5.73 p/Share	2,829 Reduced 0.41%	689,390 Common Stock, $0.0001 ...

Also insider at

ANNX

Annexon, Inc. Healthcare

CHIEF MEDICAL OFFICER

Jamie Dananberg

Chief Medical Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UBX shares.

Notify only if

Value

Insider Trading

Get notified when an Unity Biotechnology, Inc. insider buys or sells UBX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Unity Biotechnology, Inc.

Track Activities on UBX

Account